Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

What starts as breathlessness can turn fatal within minutes, doctors warn that quick action, correct inhaler use and timely ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

On average, 10.6% of Louisiana adults reported ever being told by a health professional that they have asthma. These parishes ...

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | Tuesday ...

The parents of a 13-year-old girl who died after an asthma attack led to a cardiac arrest have said they fear "other families ...

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...